ATE420882T1 - Verfahren zur synthese von n-ä3-(3- cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n- ethylacetamid - Google Patents
Verfahren zur synthese von n-ä3-(3- cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n- ethylacetamidInfo
- Publication number
- ATE420882T1 ATE420882T1 AT05708499T AT05708499T ATE420882T1 AT E420882 T1 ATE420882 T1 AT E420882T1 AT 05708499 T AT05708499 T AT 05708499T AT 05708499 T AT05708499 T AT 05708499T AT E420882 T1 ATE420882 T1 AT E420882T1
- Authority
- AT
- Austria
- Prior art keywords
- ethylacetamide
- phenylü
- synthesis
- propenyl
- dimethylamino
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- FZSDJRKAWHMQFF-UHFFFAOYSA-N n-[3-[3-(dimethylamino)prop-2-enoyl]phenyl]-n-ethylacetamide;hydrochloride Chemical compound Cl.CCN(C(C)=O)C1=CC=CC(C(=O)C=CN(C)C)=C1 FZSDJRKAWHMQFF-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0400325A HUP0400325A3 (en) | 2004-02-02 | 2004-02-02 | Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE420882T1 true ATE420882T1 (de) | 2009-01-15 |
Family
ID=89981959
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05708499T ATE420882T1 (de) | 2004-02-02 | 2005-01-31 | Verfahren zur synthese von n-ä3-(3- cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n- ethylacetamid |
| AT08008434T ATE438647T1 (de) | 2004-02-02 | 2005-01-31 | N-ä3- ä3-(dimethylamino)-1-oxo-2-propenylüphenylü-n-e hyl-acetamide hydrochlorid |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08008434T ATE438647T1 (de) | 2004-02-02 | 2005-01-31 | N-ä3- ä3-(dimethylamino)-1-oxo-2-propenylüphenylü-n-e hyl-acetamide hydrochlorid |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1950213B1 (de) |
| JP (1) | JP2007519700A (de) |
| AT (2) | ATE420882T1 (de) |
| DE (2) | DE602005012365D1 (de) |
| EA (1) | EA010830B1 (de) |
| HU (1) | HUP0400325A3 (de) |
| NO (1) | NO20063917L (de) |
| RS (1) | RS20060427A (de) |
| WO (1) | WO2005073235A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005099712A2 (en) * | 2004-04-19 | 2005-10-27 | Sanmar Speciality Chemicals Limited | Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide |
| WO2006070244A2 (en) * | 2004-11-22 | 2006-07-06 | Bakulesh Mafatlal Khamar | A process for the preparation of zaleplon |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4626538A (en) | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
| US5714607A (en) | 1995-12-01 | 1998-02-03 | American Cyanamid Company | Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide |
| TR200402588T3 (tr) * | 2001-06-12 | 2004-11-22 | Biogal Gyogyszergyar Rt | N-[3-(3-siyanopirazolo[1,5-A]pirimidin-7-il)fenil]-N- etilasetamidin(zaleplon) üretim işlemi |
| CA2453751A1 (en) * | 2001-08-01 | 2003-02-13 | Biogal Gyogyszergyar Rt. | Purification and crystalline forms of zapelon |
| PL207322B1 (pl) * | 2002-05-14 | 2010-11-30 | Adamed Społka Z Ograniczoną Odpowiedzialnością | Sposób wytwarzania zaleplonu |
-
2004
- 2004-02-02 HU HU0400325A patent/HUP0400325A3/hu unknown
-
2005
- 2005-01-31 DE DE602005012365T patent/DE602005012365D1/de not_active Expired - Fee Related
- 2005-01-31 AT AT05708499T patent/ATE420882T1/de not_active IP Right Cessation
- 2005-01-31 AT AT08008434T patent/ATE438647T1/de not_active IP Right Cessation
- 2005-01-31 EA EA200601417A patent/EA010830B1/ru not_active IP Right Cessation
- 2005-01-31 EP EP08008434A patent/EP1950213B1/de not_active Expired - Lifetime
- 2005-01-31 JP JP2006550312A patent/JP2007519700A/ja active Pending
- 2005-01-31 RS RSP-2006/0427A patent/RS20060427A/sr unknown
- 2005-01-31 DE DE602005015902T patent/DE602005015902D1/de not_active Expired - Fee Related
- 2005-01-31 EP EP05708499A patent/EP1711501B1/de not_active Expired - Lifetime
- 2005-01-31 WO PCT/HU2005/000008 patent/WO2005073235A2/en not_active Ceased
-
2006
- 2006-09-01 NO NO20063917A patent/NO20063917L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1950213A3 (de) | 2008-08-13 |
| DE602005015902D1 (de) | 2009-09-17 |
| ATE438647T1 (de) | 2009-08-15 |
| RS20060427A (sr) | 2008-08-07 |
| EP1950213A2 (de) | 2008-07-30 |
| EA200601417A1 (ru) | 2006-12-29 |
| JP2007519700A (ja) | 2007-07-19 |
| NO20063917L (no) | 2006-11-01 |
| HUP0400325A3 (en) | 2005-11-28 |
| HU0400325D0 (en) | 2004-04-28 |
| EP1711501A2 (de) | 2006-10-18 |
| WO2005073235A3 (en) | 2005-10-06 |
| HUP0400325A2 (hu) | 2005-09-28 |
| EA010830B1 (ru) | 2008-12-30 |
| EP1950213B1 (de) | 2009-08-05 |
| DE602005012365D1 (de) | 2009-03-05 |
| WO2005073235A2 (en) | 2005-08-11 |
| EP1711501B1 (de) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE442359T1 (de) | Kristalline formen von (r)-8-chlor-1-methyl-2,3,4,5-tetrahydro-1h-3-be zazepinhydrochlorid | |
| ATE445587T1 (de) | Verfahren zur herstellung von cinacalcet hydrochlorid kristallform i | |
| DE602004004663D1 (de) | Verfahren zur herstellung von 2- (chinoxalin-5-ylsulfonylamino) -benzamid-verbindungen | |
| DE60330357D1 (de) | Verfahren zur herstellung von 3-halogen-4,5-dihydro-1 h-pyrazolen | |
| ATE507224T1 (de) | Verfahren und zwischenverbindungen zur herstellung von n4-phenyl-quinazolin-4-amin derivaten | |
| ATE443038T1 (de) | Verfahren zur herstellung von cinacalcet hydrochlorid | |
| ATE398121T1 (de) | Neue synthese von irbesartan | |
| ATE444950T1 (de) | Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid | |
| ATE424892T1 (de) | Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins | |
| ATE420882T1 (de) | Verfahren zur synthese von n-ä3-(3- cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n- ethylacetamid | |
| ATE499352T1 (de) | Verfahren zur herstellung von n- (diphenylmethyl)piperazinen | |
| DE50309260D1 (de) | Verfahren zur herstellung von bicalutamid | |
| ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
| ATE330612T1 (de) | Verfahren zur herstellung von benazeprilhydrochloride | |
| ATE380183T1 (de) | Verfahren zur herstellung von phenyltetrazolderivaten | |
| ATE469141T1 (de) | Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten | |
| DE60336986D1 (de) | Verfahren zur herstellung von biarylverbindungen | |
| DE60302911D1 (de) | Verfahren zur Herstellung von Alkyl-Harnstoffen aus O,S-Dimethyl-dithiocarbonaten | |
| ATE473213T1 (de) | Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus | |
| ATE387423T1 (de) | Verfahren zur herstellung der enantiomeren formen von 2,3-diaminopropionsäurederivaten | |
| ATA14832002A (de) | Verbessertes verfahren zur herstellung von n-substituierten amiden aus nitrilen | |
| DE50312447D1 (de) | Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin | |
| DE602006006334D1 (de) | Verfahren zur herstellung von aminosäurederivaten | |
| DE60318319D1 (de) | Verfahren zur herstellung von modifikation i von n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3 pyridinsulfonamid | |
| ATE516278T1 (de) | Verfahren zur herstellung von amidverbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |